恩帕吉菲
医学
射血分数
心力衰竭
尿酸
内科学
心脏病学
二羟基化合物
射血分数保留的心力衰竭
糖尿病
内分泌学
2型糖尿病
环氧树脂
有机化学
化学
双酚A
作者
Wolfram Doehner,Stefan D. Anker,Javed Butler,Faı̈ez Zannad,Jingmei Li,Andrew J.S. Coats,João Pedro Ferreira,Ingrid Henrichmoeller,Martina Brueckmann,Elke Schueler,Stuart J. Pocock,James L. Januzzi,Milton Packer
标识
DOI:10.1016/j.jchf.2024.08.020
摘要
Sodium-glucose cotransporter 2 (SGLT2) inhibitors improve outcome in patients with heart failure (HF) and reduce serum uric acid (SUA). The relevance of this metabolic effect in patients with heart failure with preserved ejection fraction (HFpEF) is unclear.
科研通智能强力驱动
Strongly Powered by AbleSci AI